| Axon ID |
Name |
Description |
From price |
|
1128
|
Erlotinib hydrochloride
|
EGFR tyrosine kinase inhibitor |
€70.00 |
|
1393
|
Gefitinib
|
EGFR tyrosine kinase inhibitor |
€70.00 |
|
1395
|
Lapatinib ditosylate
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00 |
|
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€50.00 |
|
1433
|
CI 1033
|
EGFR tyrosine kinase inhibitor |
€60.00 |
|
1506
|
WZ 4002
|
EGFR kinase inhibitor (T790M specific) |
€70.00 |
|
1526
|
Neratinib
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00 |
|
1544
|
BIBW 2992
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€50.00 |
|
1632
|
OSI 420
|
EGFR tyrosine kinase inhibitor |
€90.00 |
|
1653
|
AEE 788
|
EGFR, ErbB2 and VEGFR tyrosine kinase inhibitor |
€80.00 |
|
1665
|
Pelitinib
|
EGFR tyrosine kinase inhibitor |
€90.00 |
|
1760
|
EGFR Inhibitor [879127-07-8]
|
Highly selective EGFR tyrosine kinase inhibitor |
€120.00 |
|
1986
|
AST 1306 tosylate
|
ErbB2 and EGFR inhibitor |
€90.00 |
|
2342
|
AZD9291
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00 |
|
2563
|
AZD3759
|
Potent, orally active, brain-penetrant, EGFR tyrosine kinase inhibitor |
€85.00 |
|
2680
|
EAI045
|
Allosteric EGFR inhibitor (L858R/T790M-specific) |
€105.00 |
|
2920
|
Poziotinib
|
Irreversible pan-HER inhibitor |
€95.00 |
|
2955
|
NSC 228155
|
EGFR tyrosine kinase activator; Inhibitor of KIX-KID interaction |
€75.00 |
|
3040
|
Abivertinib
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00 |
|
3192
|
EMI48
|
Inhibitor of EGFR triple mutants |
€120.00 |
|
3862
|
BGB-283
|
Orally available dual RAF kinase/EGFR inhibitor |
Inquire |
|
4074
|
AZ5104
|
EGFR inhibitor |
Inquire |
|
4138
|
CUDC-101
|
Potent HDAC, EGFR, and HER2 inhibitor |
Inquire |
|
4130
|
PELI1/EGFR disruptor S62
|
Potent PELI1/EGFR disruptor |
Recently added
|
€130.00 |